YHLO

2023-07-27

Summary:





From July 25-27, YHLO showcased the CLIA solutions at AACC.

Throughout the showcasing of the iFlash family, YHLO has demonstrated remarkable proficiency and expertise in Research and Development, alongside a relentless commitment to innovation. The invaluable core competencies have been a crucial element of the partnership, contributing significantly to the success in the future.

Previous: YHLO shines at Medlab Asia & Asia Health 2023

Next: YHLO showcased in EUROMEDLAB at Roma, Europe Distributor Meeting held

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +

Clinical Solution CLIA ELISA LIA ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +